Come up with a name for your new list and we'll add to it:
Vedanta Biosciences raised a round of funding on July 10, 2018. Investors include
Crohn's & Colitis Foundation of America.
Vedanta Biosciences has built a proprietary platform for the discovery, development, and manufacturing of drugs based on live commensal microbes. Using Vedanta's platform, the company has isolated a v…